American College of Cardiology Names Ravee Kurian COO/CFO

American College of Cardiology reports Ravee Kurian has been named Executive Vice President and Chief Operating Officer/Chief Financial effective July 1. Kurian will lead the global organization’s strategic planning, finance and technology divisions, while working closely with the ACC’s leadership team to advance the College’s digital transformation initiatives.

When the world was hit by the biggest public health crisis of our lifetimes, the ACC’s Board and Staff pivoted quickly to accommodate the rapidly shifting needs of the organization and its members,” Kurian said. “The ACC’s ability to do this without skipping a beat demonstrated exceptional levels of professionalism and commitment by every single person involved. I am honored and humbled to join this dedicated group as a member of the leadership team and I look forward to helping the College move confidently into the future.”

Kurian comes to ACC following a 20-year stint at Publicis Sapient, a leading technology and communications consultancy, where he led critical and sensitive digital transformation initiatives for Fortune 500 and U.S. federal clients.

Over the course of his career, Kurian has worked in a broad range of industries, including aerospace, trucking, insurance, defense and medical research. His most recent experience has been at the National Institutes of Health (NIH) where he worked with researchers, physicians and content strategists to develop a digital-first mindset that helped align their technology investments with how their audiences were interacting with their content. Previously, he also worked at Ernst & Young and at Landauer Associates, a real estate valuation and research firm.

Kurian holds a Master of Business Administration from the Kellogg School of Management at Northwestern University and a Bachelor of Science from the University of Massachusetts at Amherst.

Hot this week

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution